<DOC>
	<DOC>NCT00614757</DOC>
	<brief_summary>The purpose of this study is to evaluate how often patients with hepatitis C infection have abnormalities of sugar and fat utilization. Additionally we would like to find out if these abnormalities of sugar and fat utilization are common in other liver diseases, or related to being overweight.</brief_summary>
	<brief_title>Insulin Resistance Study</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Ability to give written consent HCV RNA PCR positive for 6 months Normal Hgb, WBC,Neutrophils Platelets of &gt;/= 65,000 Direct Bili, within 20% ULN Albumin &gt;3 Serum Creatinine &lt;20% ULN TSH WNL AFP &lt;/= 100 Women who are pregnant or breastfeeding No Thiazolidinedione, Metformin,unless required for the treatment of type II DM Hepatitis C of nongenotype 1,2,3 Any other cause for liver disease other than chronic hepatitis C Hemoglobinopathies Evidence of advanced liver disease Previous organ transplant Severe psychiatric disorder Significant cardiovascular dysfunction within the past 12 months Poorly controlled diabetes mellitus Immunologically mediated disease Any medical condition requiring chronic systemic administration of steroids Evidence of an active or suspected cancer Substance abuse at the time of the study Known HIV Irritability or unwillingness to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>